ArticleFrontiers in oncology2025
Predicting lymphovascular space invasion in early-stage cervical squamous cell carcinoma using heart rate variability.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate preoperative assessment of lymphovascular space invasion (LVSI) in patients with early-stage cervical squamous cell carcinoma (ECSCC) is clinically significant for guiding treatment decisions and predicting prognosis. However, current LVSI assessment of ECSCC mainly relies on the invasive method of pathological biopsy, which needs to be further improved in terms of convenience. The main objective of this study is to verify the value of preoperative heart rate variability (HRV) parameters in predicting ECSCC LVSI. Methods: A total of 79 patients with ECSCC confirmed by postoperative pathology were enrolled in this study at the Department of Gynecologic Oncology of the First Affiliated Hospital of Bengbu Medical University. Patients were classified as LVSI-positive (LVSI+) or LVSI-negative (LVSI-) based on pathological examination. Preoperative 5-minute electrocardiogram (ECG) data were collected from all patients, and their HRV parameters were analysed, including 7 time-domain parameters, 5 frequency-domain parameters, and 2 nonlinear parameters. Ten HRV features were selected through univariate analysis, and a logistic model was constructed using age, body mass index, menopausal status, and mean heart rate to predict LVSI status. The model performance was evaluated by the area under the receiver operating characteristic curve (AUC), accuracy, precision, sensitivity, and specificity. Results: The constructed model showed good predictive performance, with an AUC of 0.845 (95% CI: 0.761 - 0.930), sensitivity of 0.871, specificity of 0.750, precision of 0.690, and accuracy of 0.747. Conclusions: The Logistic model constructed based on HRV features has a relatively good diagnostic performance in predicting the LVSI status of ECSCC, but further research is still needed through larger datasets, more features, and the combination of machine learning models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.